Skip to content

Group News

Shelys Africa Limited

May 5, 2008

Aspen Pharmacare Holdings Limited is pleased to announce the conclusion of a deal for the acquisition of 60% of the share capital of Shelys Africa Limited, with operations in East and Central Africa with effect from 01 May 2008. Shelys Africa Limited is the holding company of a group of East African pharmaceutical companies (“the…

Read More >>

Motivation, direction and structure!

Apr 15, 2008

After my interview with him it once again dawned on me how important it is to enjoy what you do; to have a passion for it; to be motivated! In fact, when I carefully reflect on all the interviews with great leaders the recipe for success becomes clearer and clearer: You have to have motivation,…

Read More >>

Aspen records 15% year-on-year revenue increase

Feb 25, 2008

Johannesburg – JSE listed Aspen (Apn), Africa’s largest pharmaceutical manufacturer, has recorded consistently positive results for the period ended December 2007. Revenue increased by 15 percent to R2.2 billion (R1.9 billion). Operating profit increased by 24 percent to R634 million (R 512 million). Earnings per share increased by 31 percent to 125.0 cents (95.3 cents).…

Read More >>

Aspen and Strides Enter Into Broad and Strategic Partnership

Nov 20, 2007

Johannesburg South Africa, and Bangalore, India: Aspen Pharmacare (Aspen), Africa’s largest pharmaceutical manufacturer and the largest generics manufacturer in the southern hemisphere, has entered into a series of transactions with Bangalore-based Strides Arcolab Limited (Strides), one of India’s largest exporters of pharmaceutical products. The transactions comprise: the acquisition by Aspen of 50% of Strides’ Latin…

Read More >>

Aspen operating profit exceeds R1bn

Aug 20, 2007

Johannesburg – JSE listed Aspen (Apn), Africa’s largest pharmaceutical manufacturer, has announced a sound set of results for the financial year ended June 30, 2007. These results take into account the higher effective tax rate of 28,9% (2006:25.3 percent). Revenue increased by 17% to R4,026 billion (R3.449 billion). Operating profit increased by 20% to R1,077…

Read More >>

Aspen Scientific and Technical capabilities provide strong export growth potential

May 16, 2007

JSE listed Aspen (APN), Africa and the Southern hemisphere’s largest pharmaceutical manufacturer, has hosted the Honourable Minister Mosibudi Mangena, MP, South African Minister of Science and Technology, at their flagship Port-Elizabeth manufacturing site. The visit was aimed at exploring areas where the Department of Science and Technology (DST) can support local manufacturers in realising greater…

Read More >>

Key ARV Products Viread® and Truvada® Registered by MCC

Apr 24, 2007

JSE listed Aspen, a leading global manufacturer and distributor of anti-retroviral (ARV) medicines, today announced that it has been granted certification from the Medicines Control Council of South Africa (MCC) to manufacture and distribute the two key ARV products Viread® (tenofovir disoproxil fumarate) and Truvada® (emtricitabine and tenofovir disoproxil fumarate) in the South African market.…

Read More >>

Tibotec and Aspen Collaborate on PREZISTA™ access plan for Africa

Apr 4, 2007

Co Cork, Ireland (April 4th, 2007) – Tibotec Pharmaceuticals Ltd. has signed a royalty-free, non-exclusive license agreement with Aspen of South Africa. Aspen will register, package and distribute the protease inhibitor PREZISTA™ (darunavir, DRV) in sub-Saharan Africa. Tibotec has selected Aspen because of the company’s extensive African distribution network and pioneering endeavors in enhancing access…

Read More >>

Aspen and Strides enter into broad and strategic partnership

Mar 7, 2007

Johannesburg South Africa, and Bangalore, India: Aspen Pharmacare (Aspen), Africa’s largest pharmaceutical manufacturer and the largest generics manufacturer in the southern hemisphere, has entered into a series of transactions with Bangalore-based Strides Arcolab Limited (Strides), one of India’s largest exporters of pharmaceutical products. The transactions comprise: the acquisition by Aspen of 50% of Strides’ Latin…

Read More >>

Aspen records 15% increase in revenue

Feb 26, 2007

Johannesburg – JSE listed Aspen (Apn), Africa’s largest pharmaceutical manufacturer, has recorded positive results for the period ended December 2006. Revenue increased by 15 percent to R1,936 billion (R1.687 billion). Net profit after tax rose 15 percent to R332 million (R288.5 million). Earnings per share increased by 13 percent to 95,3 cents (84,5 cents). Headline…

Read More >>

MEDIA ENQUIRIES

Shauneen Beukes
Group Communications Consultant
+27 31 580 8600
+27 82 389 8900
sbeukes@aspenpharma.com

Scroll To Top